Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 2/20 | 0.92 |
| ▸ | HPRT1 | P00492 | 6/20 | 0.71 |
| ▸ | PNP | P00491 | 10/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | EDNRA | P25101 | 1/20 | 0.68 |
| ▸ | HTR2A | P28223 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | HBB | P68871 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | VCP | P55072 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL571645 | 0.96 | TK1 (1.00) | TK1HPRT1PNPBLMUSP2 | |
| SCHEMBL8175624 | 0.95 | TK1 (0.97) | TK1HPRT1PNPBLMUSP2 | |
| SCHEMBL350397 | 0.92 | TK1 (0.82) | TK1HPRT1PNPBLMUSP2 | |
| SCHEMBL29286376 | 0.88 | TK1 (0.76) | TK1HPRT1PNPBLMUSP2 | |
| SCHEMBL15743134 | 0.87 | TK1 (0.76) | TK1HPRT1PNPBLMUSP2 | |
| SCHEMBL3793003 | 0.87 | TK1 (0.76) | TK1HPRT1PNP | |
| SCHEMBL8196749 | 0.86 | TK1 (0.78) | TK1HPRT1PNPBLMUSP2 | |
| SCHEMBL20012346 | 0.86 | TK1 (0.74) | TK1HPRT1PNPBLMUSP2 | |
| SCHEMBL6272731 | 0.86 | TK1 (0.74) | TK1HPRT1PNP | |
| SCHEMBL27506929 | 0.86 | TK1 (0.74) | TK1HPRT1PNPBLMUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0143987-B1 | THERAPEUTIC COMPOSITIONS ENDOWED WITH ANTIVIRAL ACTIVITY | Stendardi, Anna Gioia (IT) | 1989-02-22 | — | — | EP | claimed |
| WO-2023220428-A1 | COMPOSITIONS FOR EDITING ASS1 TRANSCRIPTS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023220440-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2023-11-16 | — | — | WO | disclosed |
| WO-2022099159-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2022-05-12 | — | — | WO | disclosed |
| US-7590493-B2 | Methods for determining hepatotoxins | OCIMUM BIOSOLUTIONS, INC. (US) | 2009-09-15 | — | — | US | disclosed |
| US-20090220970-A1 | MOLECULAR TOXICOLOGY MODELING | OCIMUM BIOSOLUTIONS, INC. | 2009-09-03 | — | — | US | disclosed |
| US-7426441-B2 | Methods for determining renal toxins | OCIMUM BIOSOLUTIONS, INC. (US) | 2008-09-16 | — | — | US | disclosed |
| US-7415358-B2 | Molecular toxicology modeling | OCIMUM BIOSOLUTIONS, INC. (US) | 2008-08-19 | — | — | US | disclosed |
| EP-1476747-A4 | MOLECULAR HEPATOTOXICOLOGY MODELING | OCIMUM BIOSOLUTIONS INC (US) | 2008-06-11 | — | — | EP | disclosed |
| US-20070124086-A1 | Molecular nephrotoxicology modeling | OCIMUM BIOSOLUTIONS, INC. | 2007-05-31 | — | — | US | disclosed |
| EP-1392871-A4 | MOLECULAR TOXICOLOGY MODELING | GENE LOGIC INC (US) | 2006-04-19 | — | — | EP | disclosed |
| US-20060078900-A1 | Molecular toxicology modeling | GENE LOGIC, INC. | 2006-04-13 | — | — | US | disclosed |
| EP-1563295-A2 | MOLECULAR NEPHROTOXICOLOGY MODELING | Gene Logic, Inc. (US) | 2005-08-17 | — | — | EP | disclosed |
| EP-1476747-A2 | MOLECULAR HEPATOTOXICOLOGY MODELING | Gene Logic, Inc. (US) | 2004-11-17 | — | — | EP | disclosed |
| WO-2004048598-A2 | MOLECULAR NEPHROTOXICOLOGY MODELING | GENE LOGIC, INC. (US) | 2004-06-10 | — | — | WO | disclosed |
| US-20040072160-A1 | Molecular toxicology modeling | OCIMUM BIOSOLUTIONS, INC. | 2004-04-15 | — | — | US | disclosed |
| EP-1392871-A2 | MOLECULAR TOXICOLOGY MODELING | Gene Logic, Inc. (US) | 2004-03-03 | — | — | EP | disclosed |
| WO-2003064624-A2 | MOLECULAR HEPATOTOXICOLOGY MODELING | GENE LOGIC, INC. (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2002095000-A2 | MOLECULAR TOXICOLOGY MODELING | GENE LOGIC, INC. (US) | 2002-11-28 | — | — | WO | disclosed |
| CN-1058598-A | NEW LINKER FOR BIOACTIVE AGENTS | ERBA CARLO SPA (IT) | 1992-02-12 | — | — | CN | disclosed |